ArticlemAbs

IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release.

John S Schardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.